Status:
COMPLETED
Insulin Glulisine, Diabetes Mellitus Type 1
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To provide local data on efficacy and safety of insulin glulisine in patients with Type 1 Diabetes Mellitus receiving insulin glargine as basic insulin therapy
Eligibility Criteria
Inclusion
- Diabetes mellitus, Type 1
- HbA1c 6.5-11.0%
- BMI \<35 kg/m²
Exclusion
- Diabetes mellitus, Type 2
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00397553
Start Date
January 1 2005
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
Moscow, Russia